Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.
To identify appropriate candidates for aggressive treatment such as radical prostatectomy or radiation therapy of localized prostate cancer (PCa), novel predictive biomarkers of PCa aggressiveness are essential. Core2 β-1,6-N-acetylglucosaminyltransferase-1 (GCNT1) is a key enzyme that forms core 2-...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4577128?pdf=render |
_version_ | 1828389516649431040 |
---|---|
author | Yuta Kojima Tohru Yoneyama Shingo Hatakeyama Jotaro Mikami Tendo Sato Kazuyuki Mori Yasuhiro Hashimoto Takuya Koie Chikara Ohyama Minoru Fukuda Yuki Tobisawa |
author_facet | Yuta Kojima Tohru Yoneyama Shingo Hatakeyama Jotaro Mikami Tendo Sato Kazuyuki Mori Yasuhiro Hashimoto Takuya Koie Chikara Ohyama Minoru Fukuda Yuki Tobisawa |
author_sort | Yuta Kojima |
collection | DOAJ |
description | To identify appropriate candidates for aggressive treatment such as radical prostatectomy or radiation therapy of localized prostate cancer (PCa), novel predictive biomarkers of PCa aggressiveness are essential. Core2 β-1,6-N-acetylglucosaminyltransferase-1 (GCNT1) is a key enzyme that forms core 2-branched O-glycans. Its expression is associated with the progression of several cancers. We established a mouse IgG monoclonal antibody (mAb) against GCNT1 and examined the relationship of GCNT1 expression to the clinicopathological status of PCa. Paraffin-embedded PCa specimens were analyzed by immunohistochemistry for GCNT1 expression using a newly established mouse anti-GCNT1 mAb by ourselves. GCNT1-positive tumor showed significantly higher Gleason score and larger tumor volume. The number of GCNT1-positive cases was significantly lower in cases of organ-confined disease than in cases of extracapsular extension. GCNT1-negative tumors were associated with significantly better prostate-specific antigen (PSA)-free survival compared with GCNT1-positive tumors. Multivariate analysis revealed that detection of GCNT1 expression was an independent risk factor for PSA recurrence. We established new methods for GCNT1 detection from PCa specimens. Immunoblotting was used to examine post-digital rectal examination (DRE) urine from PCa patients. Over 90% of GCNT1-positive PCa patients with high concentrations of PSA showed extracapsular extension. In conclusion, GCNT1 expression closely associates with the aggressive potential of PCa. Further research aims to develop GCNT1 detection in post-DRE urine as a marker for PCa aggressiveness. |
first_indexed | 2024-12-10T06:30:25Z |
format | Article |
id | doaj.art-7118485b5a1546bc8235420ec3dd2832 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-10T06:30:25Z |
publishDate | 2015-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-7118485b5a1546bc8235420ec3dd28322022-12-22T01:59:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01109e013852010.1371/journal.pone.0138520Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer.Yuta KojimaTohru YoneyamaShingo HatakeyamaJotaro MikamiTendo SatoKazuyuki MoriYasuhiro HashimotoTakuya KoieChikara OhyamaMinoru FukudaYuki TobisawaTo identify appropriate candidates for aggressive treatment such as radical prostatectomy or radiation therapy of localized prostate cancer (PCa), novel predictive biomarkers of PCa aggressiveness are essential. Core2 β-1,6-N-acetylglucosaminyltransferase-1 (GCNT1) is a key enzyme that forms core 2-branched O-glycans. Its expression is associated with the progression of several cancers. We established a mouse IgG monoclonal antibody (mAb) against GCNT1 and examined the relationship of GCNT1 expression to the clinicopathological status of PCa. Paraffin-embedded PCa specimens were analyzed by immunohistochemistry for GCNT1 expression using a newly established mouse anti-GCNT1 mAb by ourselves. GCNT1-positive tumor showed significantly higher Gleason score and larger tumor volume. The number of GCNT1-positive cases was significantly lower in cases of organ-confined disease than in cases of extracapsular extension. GCNT1-negative tumors were associated with significantly better prostate-specific antigen (PSA)-free survival compared with GCNT1-positive tumors. Multivariate analysis revealed that detection of GCNT1 expression was an independent risk factor for PSA recurrence. We established new methods for GCNT1 detection from PCa specimens. Immunoblotting was used to examine post-digital rectal examination (DRE) urine from PCa patients. Over 90% of GCNT1-positive PCa patients with high concentrations of PSA showed extracapsular extension. In conclusion, GCNT1 expression closely associates with the aggressive potential of PCa. Further research aims to develop GCNT1 detection in post-DRE urine as a marker for PCa aggressiveness.http://europepmc.org/articles/PMC4577128?pdf=render |
spellingShingle | Yuta Kojima Tohru Yoneyama Shingo Hatakeyama Jotaro Mikami Tendo Sato Kazuyuki Mori Yasuhiro Hashimoto Takuya Koie Chikara Ohyama Minoru Fukuda Yuki Tobisawa Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer. PLoS ONE |
title | Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer. |
title_full | Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer. |
title_fullStr | Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer. |
title_full_unstemmed | Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer. |
title_short | Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer. |
title_sort | detection of core2 β 1 6 n acetylglucosaminyltransferase in post digital rectal examination urine is a reliable indicator for extracapsular extension of prostate cancer |
url | http://europepmc.org/articles/PMC4577128?pdf=render |
work_keys_str_mv | AT yutakojima detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer AT tohruyoneyama detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer AT shingohatakeyama detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer AT jotaromikami detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer AT tendosato detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer AT kazuyukimori detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer AT yasuhirohashimoto detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer AT takuyakoie detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer AT chikaraohyama detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer AT minorufukuda detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer AT yukitobisawa detectionofcore2b16nacetylglucosaminyltransferaseinpostdigitalrectalexaminationurineisareliableindicatorforextracapsularextensionofprostatecancer |